Skip to main content
. 2021 Dec 15;15(4):930–941. doi: 10.1111/cts.13206

TABLE 3.

CYP3A5, tacrolimus dose and IPV

CYP3A5 nonexpressor, n = 59 CYP3A5 expressor, n = 21
IR‐tacrolimus ER‐tacrolimus LCP‐tacrolimus IR‐tacrolimus ER‐tacrolimus LCP‐tacrolimus
Tacrolimus daily dose, mg 3.7 (1.8) 4.0 (2.1) 2.6 (1.4) 9.3 (5.7) 9.4 (6.0) 5.9 (4.6)
Tacrolimus IPV, % 16.6 (10.3) 15.6 (9.5) 18.1 (7.1) 14.7 (7.8) 16.0 (9.0) 19.4 (6.4)

Results are expressed as mean (SD).

Abbreviations: ER, extended release; IR, immediate release; IPV, intrapatient variability; LCP, LifeCyclePharma.